INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
2.410
+0.060 (2.55%)
At close: Aug 22, 2025, 4:00 PM
2.370
-0.040 (-1.66%)
After-hours: Aug 22, 2025, 7:58 PM EDT

INmune Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
64104203114182232
Upgrade
Market Cap Growth
-64.80%-48.97%78.35%-37.48%-21.41%270.69%
Upgrade
Enterprise Value
317317572112207
Upgrade
Last Close Price
2.414.6711.266.3410.2017.22
Upgrade
PS Ratio
1281.417396.101309.19304.221005.5321052.15
Upgrade
PB Ratio
2.223.235.321.892.275.98
Upgrade
P/TBV Ratio
2.226.659.742.612.8610.41
Upgrade
EV/Sales Ratio
622.955207.601127.89191.85619.1418856.25
Upgrade
Debt / Equity Ratio
0.020.010.270.260.190.00
Upgrade
Asset Turnover
0.0000.000.000.000
Upgrade
Quick Ratio
4.143.092.075.5518.4313.38
Upgrade
Current Ratio
4.203.142.165.9218.9513.51
Upgrade
Return on Equity (ROE)
-168.34%-119.83%-61.09%-38.91%-51.00%-38.80%
Upgrade
Return on Assets (ROA)
-55.08%-55.19%-26.78%-17.85%-25.92%-23.47%
Upgrade
Return on Capital (ROIC)
-69.11%-65.75%-29.98%-18.98%-27.12%-24.38%
Upgrade
Earnings Yield
-86.64%-40.64%-14.79%-23.99%-16.67%-5.22%
Upgrade
Buyback Yield / Dilution
-20.28%-10.92%-0.30%-11.14%-34.55%-16.70%
Upgrade
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q